BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Press Releases

November 17, 201420th Annual BIO-Europe® 2014 partnering meetings outnumber all previous yearsSuccess of industry event confirms valued role of partnering in bringing drugs to patients
The 20th anniversary edition of BIO-Europe® international partnering conference wrapped up last week, November 3–5, in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. The conference attracted over 3,200 leading dealmakers from 54 countries comprising 1,786 companies made up of biotech, large and midsize pharma, and finance along with emerging com...  more ►

October 16, 2014BIO-Europe® 2014 Program is abundant showcase of life science pharma executives and thought leaders BIO-Europe® 2014 international partnering conference will take place, November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging...  more ►

October 8, 2014BIO-Europe® 2014 partnering meetings expected to surpass all previous events The BIO-Europe® 2014 international partnering conference will take place in one month on November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt. BIO-Europe is the largest dedicated partnering conference worldwide serving the life science industry. The 2014 Frankfurt event projects the number of one-to-one partnering meetings to surpass the 2013 all-time rec...  more ►

August 12, 2014BIO-Europe® 2014 kicks off its 20th year as life science partnering leader
Event will be held in Frankfurt, Germany this year
The twentieth annual BIO-Europe® international partnering conference will take place November 3–5 in Frankfurt, Germany, at the Portalhaus Messe Frankfurt conference center. "BIO-Europe has continued to be the leading European life science partnering event because of the high caliber companies that bring their teams to partner," said Florian Schoenhammer, Managing Direct...  more ►

August 1, 2014Spotlight on Frankfurt Business Facts The state of Hessen has top ranked cities: Frankfurt, Wiesbaden and Kassel are among the top 10 cities in Germany (based on WiWo City Ranking 2012). Frankfurt is Germany's major airport and leading hub in Europe with over 57.5 million passengers per year and 4,575 direct flight connections per week. Overall, 108 airlines fly to 295 destinations in 105 countries. There are tw...  more ►


partnering360® Blog

January 23, 2015 Recursion Pharmaceuticals: Innovative alternative to drug discovery Investment in biotech companies is increasing.  A recent article at Drug Discovery and Development shares that biotech investing was up 26% at the beginning of 2014 which equaled $2.93 billion.  Many believe it is because investments are shifting from digital to problems that need to be solved on... more ►

January 14, 2015 Biotech Showcase™ 2015 Day Three Biotech Showcase™ 2015 day three started off with the panel “Apps as drugs” moderated by Steve Dickman of CBT Advisors which gave insight into online and mobile apps and programs that augment disease platforms. There was interest in whether the apps would replace or work in conjunction with... more ►

January 14, 2015 Biotech Showcase™ 2015: Days 1 and 2 Highlights Biotech Showcase™ 2015 is in full swing on this second conference day. An estimated 2,100 delegates have been participating in 4,400 one-to-one partnering meetings this year, an all-time high. The Alliance for Regenerative Medicine’s (ARM)“Regenerative Medicine and Advanced Therapies State of... more ►

January 12, 2015 ARM State of the Industry Briefing gives clear evidence that regen med/advanced therapies are the next big thing in biotech Biotech Showcase™ 2015 kicked off today with the Alliance for Regenerative Medicine’s (ARM) Regenerative Medicine and Advanced Therapies State of the Industry Briefing. Edward Lanphier, President and CEO of Sangamo BioScience and the new Chair of the Alliance for Regenerative Medicine gave... more ►

January 9, 2015 Translational medicine: The key to a thriving life science industry In this short video, key players in the respiratory disease field in Europe look at it’s importance and hwo a thriving translational medicine field can help enhance the life sciences industries, public health and health life science economies.  Due to the intense regulatory process that have... more ►



partnering360:Insight Latest headlines from partnering360:Insight

January 22, 2015 Life sciences democratize research and investing Non-accredited investors are beginning to have the opportunity to invest in biotech, thanks to some innovative new financing mechanisms and the growing democratization of healthcare, according to panelists at the Biotech Showcase™ 2015 financing session. more ►

January 16, 2015 Are old financing models enough? Last year saw more than USD 400 billion returned to investors through IPO exits and a bevy of new venture funds created, but this doesn’t signal a return to business as usual. Instead biotech financing in the future must continue to look to innovative strategies and must address reimbursement questions ever earlier in the race to attract funds, according to panelists at a Biotech Showcase™ 2015 lunch plenary. more ►

January 16, 2015 Regenerative medicine creating tangible value Regenerative medicine is beginning to add real value to healthcare not just by treating disease, but by curing disease. Most people—even those in the industry—don’t realize that more than 60 regenerative products have been approved, said Edward Lanphier. Some 500 companies are operating in this space globally, with 375 ongoing clinical trials. Of those, 340 are in Phase I or Phase II. Therefore, a great many products can be expected to be commercialized in the next few years. more ►

January 16, 2015 Perceptions of value and success There’s no single definition of value in the life sciences. Big pharma, investment bankers and venture capitalists each have different goals that affect their perception of value and guide their investment decisions. Panelists at a luncheon plenary session at Biotech Showcase™ 2015 made that point patently evident. more ►

January 16, 2015 The new immuno-oncology revolution Immuno-oncology is new again, fueled by research that has many scientists thinking a cure for cancer may be possible within their lifetimes. After the cancer vaccine misses of seven years ago, investors’ interests are once again piqued. The challenge is identifying exactly where in this fast-moving, complicated space to invest, according to Stephen Dunn, President and Senior Managing Partner, LifeTech Capital, speaking at Biotech Showcase™ 2015. more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD GmbH
Privacy Policy
Terms of Use
BIO-Europe EBD Group BIO BIO-Europe